Welcome to Philadelphia.legalexaminer.com - The Legal Examiner Affiliate Network

philadelphia.legalexaminer.com

Description: Philadelphia Legal Examiner. Straightforward legal news, analysis, and opinion published by lawyers & industry experts..

Google PR 4

Trustworthiness Unknown
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Unknown

The Legal Examiner Affiliate Network | Legal News & Commentary

Philadelphia.legalexaminer.com: get to the top rated Philadelphia Legal Examiner pages and content popular with USA-based Philadelphia.legalexaminer.com users or check the following digest to find out more. Philadelphia.legalexaminer.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Philadelphia Legal Examiner team are just starting to conquer the social media and they have already achieved a promising result — 8 user activities so far (Twitter dominates with around 82% of all user reactions). Philadelphia.legalexaminer.com is hosted with WPEngine, Inc. in Spain. Philadelphia Legal Examiner traffic is not yet estimated by Alexa.

Visit philadelphia.legalexaminer.com

Domain info

Location:	Spain
Registrant:	REDACTED FOR PRIVACY
Hosted by:	WPEngine, Inc.
Registrar:	Squarespace Domains II LLC
Subnetworks:	141.193.213.10, 141.193.213.11

Social Media Activities

Facebook likes: -
Twitter mentions: 7
Google pluses: 1
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Philadelphia.legalexaminer.com popular pages to visit

Massive Fraud In Merck MMR Vaccine Testing Merck’s Measles-Mumps-Rubella (MMR) vaccine is under fire following allegations of wrongdoing from several parties, namely two former Merck scientists-turned-whistleblowers. A third whistleblower is a...

The Legal Examiner Affiliate Network | Legal News & Commentary Straightforward legal news, analysis, and opinion published by lawyers & industry experts.

$15.5 Million Settlement in Risperdal Failure to Warn, Off-Label Marketing Lawsuit A settlement of $15.5 million was reached between the Kentucky Attorney General and Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) regarding the drug Risperdal, used widely to treat schiz...